tambaku Based upon recent studies of 2004-2009 FDA adverse event reports, researchers believe that Byetta may unintentionally trigger growth in pancreatic gland ducts leading to pancreatitis and even pancreatic cancer. Similar data exists for Januvia and the FDA recently mandated that the manufacturer update the drug’s warning label to inform patients of certain pancreatic risks when taking Januvia.

Individuals all across the country who were injured after taking Byetta or Januvia are beginning to file lawsuits, claiming these drugs were responsible for their injuries and if given the proper warnings, they could have used safer, more effective medications instead.

If you or a loved one took Byetta or Januvia and were diagnosed with:

  • Pancreatitis
  • Pancreatic Cancer
  • Thyroid Cancer

You may be entitled to significant compensation from the manufacturer.

Contact National Information Systems today to speak with an experienced attorney to determine if you may qualify. There are time deadlines to file a claim so don’t wait – act now.

Fields marked with a * are required.


Connect immediately with a
National Information Systems attorney